Sophie Vaillot

Sophie Vaillot is a seasoned professional in regulatory affairs with extensive experience in the life sciences sector. Currently serving as the Senior Director of Regulatory Affairs EMEA at Boston Scientific since October 2023, Sophie previously held the position of Global Head of Regulatory Affairs at Vectura Fertin Pharma, where expertise in inhalation and oral delivery systems was leveraged. Prior to that, Sophie was the Global Head of Life Sciences Regulatory Affairs at Philip Morris International, focusing on regulatory strategy and compliance for new product developments. Sophie's career also includes leadership roles in regulatory affairs at Nobel Biocare Systems and GE Healthcare, emphasizing strategic planning and compliance management. Educational qualifications include a Doctor of Pharmacy and a degree in Regulatory Affairs from Université de Tours.